EGFR-GRB2 Protein Colocalization Is a Prognostic Factor Unrelated to Overall EGFR Expression or EGFR Mutation in Lung Adenocarcinoma

about

MET-GRB2 Signaling-Associated Complexes Correlate with Oncogenic MET Signaling and Sensitivity to MET Kinase Inhibitors.TRAF6 regulates EGF-induced cell transformation and cSCC malignant phenotype through CD147/EGFR.

P2860

Q40064345-60E6734F-B9FF-489D-A74E-D2E45E24D361 Q49789503-4BDDACEA-2587-4E69-A34B-5DA88B39B37C

P2860

EGFR-GRB2 Protein Colocalization Is a Prognostic Factor Unrelated to Overall EGFR Expression or EGFR Mutation in Lung Adenocarcinoma

Item

http://www.wikidata.org/entity/Q38807586

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

EGFR-GRB2 Protein Colocalizati ...... utation in Lung Adenocarcinoma

@en

type

Item

label

EGFR-GRB2 Protein Colocalizati ...... utation in Lung Adenocarcinoma

@en

prefLabel

EGFR-GRB2 Protein Colocalizati ...... utation in Lung Adenocarcinoma

@en

P1476

EGFR-GRB2 Protein Colocalizati ...... utation in Lung Adenocarcinoma

@en

P2093

Brian Henick

http://www.w3.org/2001/XMLSchema#string

Daniel E Carvajal-Hausdorf

http://www.w3.org/2001/XMLSchema#string

David L Rimm

http://www.w3.org/2001/XMLSchema#string

Joseph McLaughlin

http://www.w3.org/2001/XMLSchema#string

Konstantinos N Syrigos

http://www.w3.org/2001/XMLSchema#string

Maria I Toki

http://www.w3.org/2001/XMLSchema#string

Mehmet Altan

http://www.w3.org/2001/XMLSchema#string

P2860

In situ analysis of mutant EGFRs prevalent in glioblastoma multiforme reveals aberrant dimerization, activation, and differential response to anti-EGFR targeted therapy

The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling

Protein phosphorylation profiling using an in situ proximity ligation assay: phosphorylation of AURKA-elicited EGFR-Thr654 and EGFR-Ser1046 in lung cancer cells

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

EGFR testing in lung cancer is ready for prime time

Erlotinib in previously treated non-small-cell lung cancer

Epidermal growth factor receptor mutations in lung cancer

Direct observation of individual endogenous protein complexes in situ by proximity ligation

Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer

Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study.

P304

1901-1911

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JTHO.2016.06.025

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kurt A Schalper

P577

2016-07-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27449805

http://www.w3.org/2001/XMLSchema#string

P932

5075503

http://www.w3.org/2001/XMLSchema#string

EGFR-GRB2 Protein Colocalization Is a Prognostic Factor Unrelated to Overall EGFR Expression or EGFR Mutation in Lung Adenocarcinoma

about

P2860

P2860

EGFR-GRB2 Protein Colocalization Is a Prognostic Factor Unrelated to Overall EGFR Expression or EGFR Mutation in Lung Adenocarcinoma

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932